The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease
Trial details
- Registry ID
- NCT04674358
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye DiseaseNCT04674358 | ALDX | Phase 2, Phase 3 | Completed | 2021-09-12Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |